ALTAN PHARMACEUTICALS, S.A. (manufacturing of finished dosage form, primary and secondary packaging, quality control, including identification analysis (test A), related substances and polymyxin composition profile, and batch release)

The drug is prescribed for adults and children (including newborns) to treat severe infections caused by certain Gram-negative bacteria. It is also used in inhalation form to treat chronic pulmonary infections in patients with cystic fibrosis.

Dosage form: powder for solution for injection or inhalation

ATC: J01XB01